Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dietary Supplements | 17 | 2019 | 2251 | 2.04 | Why? |
| Lipids | 10 | 2019 | 1079 | 1.73 | Why? |
| Ubiquinone | 4 | 2018 | 91 | 1.73 | Why? |
| Metabolic Diseases | 7 | 2018 | 505 | 1.52 | Why? |
| Iran | 26 | 2021 | 5467 | 1.19 | Why? |
| Metabolic Syndrome | 6 | 2019 | 810 | 0.99 | Why? |
| Accidents, Traffic | 3 | 2018 | 464 | 0.96 | Why? |
| Randomized Controlled Trials as Topic | 20 | 2019 | 10649 | 0.85 | Why? |
| Cholangitis, Sclerosing | 2 | 2018 | 106 | 0.80 | Why? |
| Synbiotics | 2 | 2019 | 15 | 0.78 | Why? |
| Hepatolenticular Degeneration | 1 | 2018 | 62 | 0.71 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.66 | Why? |
| Folic Acid | 2 | 2018 | 172 | 0.63 | Why? |
| Gastrointestinal Agents | 1 | 2020 | 393 | 0.62 | Why? |
| Blood Glucose | 7 | 2020 | 3642 | 0.62 | Why? |
| Cholangiocarcinoma | 1 | 2018 | 186 | 0.59 | Why? |
| Bile Duct Neoplasms | 1 | 2018 | 172 | 0.59 | Why? |
| Physicians, Family | 1 | 2018 | 208 | 0.58 | Why? |
| Liver Failure, Acute | 1 | 2018 | 279 | 0.56 | Why? |
| Automobile Driving | 1 | 2018 | 222 | 0.55 | Why? |
| Financing, Personal | 2 | 2018 | 113 | 0.52 | Why? |
| Oxidative Stress | 3 | 2018 | 2050 | 0.50 | Why? |
| Substance Abuse, Intravenous | 1 | 2017 | 411 | 0.49 | Why? |
| Curcumin | 2 | 2018 | 396 | 0.48 | Why? |
| Vitamin D | 4 | 2018 | 2904 | 0.47 | Why? |
| Family Practice | 1 | 2018 | 472 | 0.45 | Why? |
| Diabetes, Gestational | 2 | 2017 | 426 | 0.45 | Why? |
| Health Planning | 1 | 2018 | 607 | 0.44 | Why? |
| Houseflies | 1 | 2018 | 22 | 0.38 | Why? |
| Glypicans | 1 | 2018 | 4 | 0.37 | Why? |
| Gastric Mucosa | 1 | 2019 | 141 | 0.37 | Why? |
| Medicine, Arabic | 1 | 2017 | 3 | 0.37 | Why? |
| Precancerous Conditions | 1 | 2019 | 108 | 0.37 | Why? |
| Thioctic Acid | 1 | 2018 | 27 | 0.37 | Why? |
| Portal System | 1 | 2017 | 9 | 0.37 | Why? |
| Triglycerides | 2 | 2018 | 478 | 0.37 | Why? |
| Inositol | 1 | 2018 | 28 | 0.37 | Why? |
| Biomarkers | 9 | 2019 | 23361 | 0.36 | Why? |
| Inflammation | 8 | 2020 | 13255 | 0.35 | Why? |
| Liver Transplantation | 3 | 2018 | 2864 | 0.35 | Why? |
| Vitamin B Complex | 1 | 2017 | 49 | 0.35 | Why? |
| Hypokalemia | 1 | 2020 | 195 | 0.35 | Why? |
| Pimpinella | 1 | 2016 | 1 | 0.34 | Why? |
| Insulin Resistance | 2 | 2018 | 669 | 0.34 | Why? |
| Prisons | 1 | 2017 | 980 | 0.34 | Why? |
| Mesenteric Vascular Occlusion | 1 | 2017 | 43 | 0.34 | Why? |
| Cholesterol, LDL | 2 | 2018 | 499 | 0.34 | Why? |
| Government | 2 | 2021 | 1453 | 0.34 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2018 | 113 | 0.33 | Why? |
| Capsules | 1 | 2016 | 140 | 0.32 | Why? |
| Lipid Metabolism | 2 | 2018 | 572 | 0.32 | Why? |
| Gastroesophageal Reflux | 1 | 2018 | 124 | 0.32 | Why? |
| Insect Vectors | 1 | 2018 | 227 | 0.31 | Why? |
| Sleep Wake Disorders | 1 | 2018 | 1463 | 0.31 | Why? |
| Gastroenterologists | 1 | 2020 | 259 | 0.31 | Why? |
| Medicine, Traditional | 1 | 2018 | 189 | 0.31 | Why? |
| Plant Oils | 1 | 2016 | 86 | 0.31 | Why? |
| Quercetin | 1 | 2019 | 297 | 0.30 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.30 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.30 | Why? |
| Polycystic Ovary Syndrome | 1 | 2018 | 151 | 0.29 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.29 | Why? |
| Oils, Volatile | 1 | 2016 | 127 | 0.29 | Why? |
| Endothelium | 1 | 2018 | 460 | 0.28 | Why? |
| Irritable Bowel Syndrome | 1 | 2016 | 175 | 0.27 | Why? |
| Stomach Neoplasms | 1 | 2019 | 477 | 0.27 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2017 | 907 | 0.26 | Why? |
| Pregnant Women | 2 | 2021 | 2535 | 0.25 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.25 | Why? |
| Religion | 1 | 2017 | 353 | 0.25 | Why? |
| Risk-Taking | 1 | 2017 | 508 | 0.24 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.24 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.24 | Why? |
| Risk | 3 | 2021 | 5288 | 0.24 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2018 | 6166 | 0.24 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.24 | Why? |
| Antioxidants | 2 | 2018 | 1593 | 0.23 | Why? |
| Health Care Reform | 1 | 2017 | 409 | 0.22 | Why? |
| Humans | 65 | 2021 | 930598 | 0.22 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.22 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.22 | Why? |
| Melatonin | 1 | 2018 | 578 | 0.22 | Why? |
| Probiotics | 1 | 2019 | 694 | 0.22 | Why? |
| Hepatitis B, Chronic | 1 | 2018 | 616 | 0.21 | Why? |
| Public Opinion | 1 | 2021 | 1165 | 0.21 | Why? |
| Sialorrhea | 1 | 2020 | 24 | 0.21 | Why? |
| Celiac Disease | 1 | 2007 | 471 | 0.21 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.21 | Why? |
| Lymphocytes | 2 | 2020 | 3056 | 0.21 | Why? |
| Long QT Syndrome | 1 | 2020 | 1047 | 0.21 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.20 | Why? |
| Publication Bias | 3 | 2018 | 241 | 0.20 | Why? |
| Delivery, Obstetric | 1 | 2018 | 1292 | 0.18 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.18 | Why? |
| Genistein | 1 | 2017 | 25 | 0.17 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.17 | Why? |
| Urban Health Services | 1 | 2018 | 125 | 0.17 | Why? |
| Health Expenditures | 2 | 2018 | 904 | 0.16 | Why? |
| Electrochemical Techniques | 1 | 2020 | 406 | 0.16 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.16 | Why? |
| Adult | 25 | 2021 | 244371 | 0.16 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.16 | Why? |
| Mental Disorders | 2 | 2020 | 6742 | 0.15 | Why? |
| Health Status | 2 | 2020 | 3259 | 0.15 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.15 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.15 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 8811 | 0.15 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.15 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.15 | Why? |
| Female | 30 | 2021 | 380317 | 0.14 | Why? |
| Cholesterol, HDL | 2 | 2018 | 439 | 0.14 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.14 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.14 | Why? |
| Emotions | 1 | 2017 | 2418 | 0.14 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.14 | Why? |
| Islam | 1 | 2020 | 545 | 0.14 | Why? |
| Malondialdehyde | 2 | 2018 | 113 | 0.13 | Why? |
| Dentistry | 1 | 2020 | 621 | 0.13 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.13 | Why? |
| Nursing Staff, Hospital | 1 | 2017 | 1554 | 0.13 | Why? |
| Glucose | 1 | 2017 | 573 | 0.13 | Why? |
| Living Donors | 1 | 2018 | 652 | 0.12 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.12 | Why? |
| Communication | 1 | 2021 | 5206 | 0.12 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.12 | Why? |
| Liver | 1 | 2017 | 4007 | 0.12 | Why? |
| Cross-Sectional Studies | 8 | 2021 | 53120 | 0.12 | Why? |
| Selenium | 1 | 2017 | 412 | 0.12 | Why? |
| Intracranial Aneurysm | 1 | 2017 | 504 | 0.12 | Why? |
| Male | 24 | 2021 | 367725 | 0.12 | Why? |
| Character | 1 | 2021 | 12 | 0.11 | Why? |
| Genetic Predisposition to Disease | 1 | 2016 | 4027 | 0.11 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.11 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.11 | Why? |
| Subarachnoid Hemorrhage | 1 | 2017 | 611 | 0.11 | Why? |
| Burnout, Professional | 1 | 2017 | 2489 | 0.11 | Why? |
| Personality Inventory | 1 | 2021 | 72 | 0.11 | Why? |
| Multiple Sclerosis | 1 | 2007 | 2600 | 0.11 | Why? |
| Temperament | 1 | 2021 | 58 | 0.11 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.11 | Why? |
| C-Reactive Protein | 4 | 2020 | 7972 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| CD4-CD8 Ratio | 1 | 2020 | 235 | 0.10 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.10 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.10 | Why? |
| Surveys and Questionnaires | 7 | 2021 | 43792 | 0.10 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.09 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.09 | Why? |
| Interleukin-6 | 4 | 2020 | 7522 | 0.09 | Why? |
| Reference Books, Medical | 1 | 2018 | 5 | 0.09 | Why? |
| Gastroscopy | 1 | 2019 | 112 | 0.09 | Why? |
| Ethnopharmacology | 1 | 2018 | 31 | 0.09 | Why? |
| Prisoners | 1 | 2017 | 738 | 0.09 | Why? |
| Students | 1 | 2017 | 5255 | 0.09 | Why? |
| Prevalence | 4 | 2018 | 25773 | 0.09 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.09 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.09 | Why? |
| Superoxide Dismutase | 1 | 2018 | 155 | 0.09 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.09 | Why? |
| Gliadin | 1 | 2007 | 26 | 0.09 | Why? |
| Pregnancy | 5 | 2021 | 23879 | 0.09 | Why? |
| Lipoprotein(a) | 1 | 2018 | 92 | 0.09 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.09 | Why? |
| History, Medieval | 1 | 2017 | 131 | 0.09 | Why? |
| Magnesium | 1 | 2020 | 290 | 0.09 | Why? |
| Parity | 1 | 2018 | 122 | 0.08 | Why? |
| Potassium | 1 | 2020 | 325 | 0.08 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.08 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.08 | Why? |
| Tissue and Organ Procurement | 1 | 2018 | 1277 | 0.08 | Why? |
| Heart Conduction System | 1 | 2020 | 266 | 0.08 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 1510 | 0.08 | Why? |
| Transfusion Reaction | 1 | 2009 | 245 | 0.08 | Why? |
| Thalassemia | 1 | 2009 | 144 | 0.08 | Why? |
| Depression | 1 | 2021 | 14116 | 0.08 | Why? |
| Duodenum | 1 | 2007 | 179 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.08 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.08 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.08 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.07 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.07 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.07 | Why? |
| Placebos | 1 | 2017 | 629 | 0.07 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.06 | Why? |
| Metabolome | 1 | 2018 | 624 | 0.06 | Why? |
| Asia | 1 | 2020 | 2399 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Fasting | 1 | 2018 | 555 | 0.06 | Why? |
| Educational Status | 1 | 2018 | 1451 | 0.06 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.06 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.06 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.06 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.05 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.05 | Why? |
| Mothers | 1 | 2021 | 1624 | 0.05 | Why? |
| Singapore | 1 | 2020 | 3641 | 0.05 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.05 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.05 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.05 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.05 | Why? |
| Electrodes | 1 | 2020 | 203 | 0.05 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.05 | Why? |
| Hepacivirus | 1 | 2009 | 1509 | 0.05 | Why? |
| Income | 1 | 2018 | 1564 | 0.05 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.05 | Why? |
| Endoscopy | 1 | 2020 | 1564 | 0.05 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.05 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.05 | Why? |
| Biliary Atresia | 1 | 2018 | 45 | 0.05 | Why? |
| Social Determinants of Health | 1 | 2020 | 1757 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.05 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.04 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.04 | Why? |
| Aged | 7 | 2020 | 215776 | 0.04 | Why? |
| Hepatitis C | 1 | 2009 | 1514 | 0.04 | Why? |
| Prenatal Care | 1 | 2018 | 1314 | 0.04 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.04 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.04 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.04 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.04 | Why? |
| Graphite | 1 | 2020 | 318 | 0.04 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.04 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.04 | Why? |
| Gold | 1 | 2020 | 592 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Immunoglobulin A | 1 | 2007 | 3567 | 0.04 | Why? |
| Interleukin-1 | 1 | 2018 | 438 | 0.04 | Why? |
| Insurance, Health | 1 | 2020 | 634 | 0.04 | Why? |
| Pilot Projects | 1 | 2016 | 5182 | 0.03 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.03 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.03 | Why? |
| Child | 4 | 2018 | 70012 | 0.03 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2020 | 771 | 0.03 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.03 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.03 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.03 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Animals | 3 | 2020 | 78931 | 0.03 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.03 | Why? |
| Physical Therapy Modalities | 1 | 2020 | 1090 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.03 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.03 | Why? |
| Waiting Lists | 1 | 2018 | 1388 | 0.02 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.02 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2020 | 2116 | 0.02 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.02 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.02 | Why? |
| Quality of Life | 1 | 2016 | 9820 | 0.02 | Why? |
| Infant | 1 | 2017 | 30274 | 0.02 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.02 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| China | 1 | 2020 | 50654 | 0.02 | Why? |
| Immunoglobulin G | 1 | 2007 | 21571 | 0.02 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.01 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Genotype | 1 | 2009 | 4697 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
Bagheri Lankarani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(280)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(118)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_